Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies.
Glader C, Jeitler R, Wang Y, Tetyczka C, Zettl M, Schlömer M, Caisse P, Mesite S, Stephan S, Bourgeaux V, Roblegg E. Glader C, et al. Among authors: zettl m. Eur J Pharm Sci. 2024 Dec 1;203:106928. doi: 10.1016/j.ejps.2024.106928. Epub 2024 Oct 6. Eur J Pharm Sci. 2024. PMID: 39378960 Free article.
Real-time prediction of dissolution profiles of coated oral dosage forms.
Sacher S, Fink E, Alva C, Alberto Afonso Urich J, Doğan A, Herndler V, Koutsamanis I, Kushwah V, Peter A, Salar-Behzadi S, Wilfling K, Stranzinger S, Zettl M, Feng X, Korang-Yeboah M, Wu H, Khinast JG. Sacher S, et al. Among authors: zettl m. Int J Pharm. 2024 Dec 5;666:124841. doi: 10.1016/j.ijpharm.2024.124841. Epub 2024 Oct 15. Int J Pharm. 2024. PMID: 39414187
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies.
Piha-Paul S, Olwill SA, Hamilton E, Tolcher A, Pohlmann P, Liu SV, Wurzenberger C, Hasenkamp LC, Hansbauer EM, Shroff R, Hurvitz S, Krishnamurthy A, Patnaik A, Hahn N, Kumar R, Duerr M, Zettl M, Aviano K, Matis L, Bruns I, Ku G. Piha-Paul S, et al. Among authors: zettl m. Clin Cancer Res. 2025 Jan 17;31(2):288-298. doi: 10.1158/1078-0432.CCR-24-1552. Clin Cancer Res. 2025. PMID: 39235868 Clinical Trial.
41 results